Transarterial‐ chemoembolization remains an effective therapy for intermediate‐stage hepatocellular carcinoma with preserved liver function-Reference-Cited by-同舟云学术

Transarterial‐ chemoembolization remains an effective therapy for intermediate‐stage hepatocellular carcinoma with preserved liver function

Published:2020-08-14 Issue:10 Volume:50 Page:1176-1185
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Saito Natsuhiko¹,Tanaka Toshihiro¹,Nishiohuku Hideyuki¹,Sato Takeshi¹,Masada Tetsuya¹,Matsumoto Takeshi¹,Anai Hiroshi²,Sakaguchi Hiroshi³,Sueyoshi Satoru⁴,Marugami Nagaaki¹,Kichikawa Kimihiko¹

Affiliation:

1. Department of Radiology, IVR Center Nara Medical University Kashihara Japan

2. Department of Radiology Nara City Hospital Nara Japan

3. Department of Radiology Minaminara Medical Center Oyodo Japan

4. Department of Radiology Saiseikai Chuwa Hospital Sakurai Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13550

Reference46 articles.

1. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.

2. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

3. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions;Bolondi L;Semin Liver Dis,2012

4. Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)

5. Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child–Pugh grade correlated with prognosis after transarterial chemoembolization

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study;Hepatology Research;2024-07-02

2. No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma;Cancer Medicine;2024-07

3. Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts;Cancers;2024-06-28

4. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma;Scientific Reports;2024-05-13

5. Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma;Cancers;2024-04-23